↓ Skip to main content

Current Advances in Osteosarcoma

Overview of attention for book
Cover of 'Current Advances in Osteosarcoma'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective
  3. Altmetric Badge
    Chapter 2 Limb Salvage and Reconstruction Options in Osteosarcoma
  4. Altmetric Badge
    Chapter 3 Advances in the Functional Assessment of Patients with Sarcoma
  5. Altmetric Badge
    Chapter 4 Radiopharmaceuticals for Treatment of Osteosarcoma
  6. Altmetric Badge
    Chapter 5 HER2-Targeted Therapy in Osteosarcoma
  7. Altmetric Badge
    Chapter 6 Aerosolized Chemotherapy for Osteosarcoma
  8. Altmetric Badge
    Chapter 7 The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma
  9. Altmetric Badge
    Chapter 8 Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the Disease
  10. Altmetric Badge
    Chapter 9 Using Liquid Biopsy in the Treatment of Patient with OS
  11. Altmetric Badge
    Chapter 10 Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s
  12. Altmetric Badge
    Chapter 11 Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma
  13. Altmetric Badge
    Chapter 12 Natural Killer Cell Immunotherapy for Osteosarcoma
  14. Altmetric Badge
    Chapter 13 Nanocapsule Delivery of IL-12
  15. Altmetric Badge
    Chapter 14 Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune Therapy
  16. Altmetric Badge
    Chapter 15 Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention
  17. Altmetric Badge
    Chapter 16 Exercise and Physical Activity in Patients with Osteosarcoma and Survivors
Attention for Chapter 12: Natural Killer Cell Immunotherapy for Osteosarcoma
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Natural Killer Cell Immunotherapy for Osteosarcoma
Chapter number 12
Book title
Current Advances in Osteosarcoma
Published in
Advances in experimental medicine and biology, June 2020
DOI 10.1007/978-3-030-43032-0_12
Pubmed ID
Book ISBNs
978-3-03-043031-3, 978-3-03-043032-0
Authors

Brian P. Tullius, Buhvana A. Setty, Dean A. Lee, Tullius, Brian P., Setty, Buhvana A., Lee, Dean A.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 2 29%
Lecturer 1 14%
Researcher 1 14%
Unknown 3 43%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 43%
Medicine and Dentistry 1 14%
Unknown 3 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2020.
All research outputs
#15,081,688
of 23,211,181 outputs
Outputs from Advances in experimental medicine and biology
#2,290
of 4,991 outputs
Outputs of similar age
#236,102
of 398,035 outputs
Outputs of similar age from Advances in experimental medicine and biology
#38
of 92 outputs
Altmetric has tracked 23,211,181 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,991 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,035 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.